Mohammad Shafiei

630 total citations
31 papers, 485 citations indexed

About

Mohammad Shafiei is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Mohammad Shafiei has authored 31 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Mohammad Shafiei's work include Radiopharmaceutical Chemistry and Applications (12 papers), Synthesis and biological activity (6 papers) and Medical Imaging Techniques and Applications (5 papers). Mohammad Shafiei is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Synthesis and biological activity (6 papers) and Medical Imaging Techniques and Applications (5 papers). Mohammad Shafiei collaborates with scholars based in Iran, United States and Türkiye. Mohammad Shafiei's co-authors include Alireza Foroumadi, Lee Peyton, Mehrnoosh Hashemzadeh, Mostafa Erfani, Mohammad Mazidi, Reza Najafi, Seyed Pezhman Shirmardi, Seyed Esmaeil Sadat Ebrahimi, Pouya Ghamari Kargar and Loghman Firoozpour and has published in prestigious journals such as ACS Omega, Frontiers in Chemistry and Heliyon.

In The Last Decade

Mohammad Shafiei

31 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Shafiei Iran 12 141 140 99 97 94 31 485
Fereidoon Daryaee United States 12 77 0.5× 94 0.7× 39 0.4× 61 0.6× 65 0.7× 18 463
Yong-Kang Zhang China 16 112 0.8× 388 2.8× 75 0.8× 182 1.9× 103 1.1× 27 924
Vidya P. Kumar United States 17 180 1.3× 49 0.3× 56 0.6× 48 0.5× 41 0.4× 47 571
Catherine Piveteau France 12 21 0.1× 94 0.7× 85 0.9× 82 0.8× 136 1.4× 25 496
Andrew Chang United States 15 33 0.2× 170 1.2× 67 0.7× 31 0.3× 86 0.9× 24 785
Weiguo Shi China 13 22 0.2× 60 0.4× 53 0.5× 56 0.6× 101 1.1× 50 483
Albert D. Friesen Canada 14 50 0.4× 53 0.4× 40 0.4× 56 0.6× 50 0.5× 26 619
Shoukath M. Ali United States 12 25 0.2× 97 0.7× 66 0.7× 89 0.9× 35 0.4× 28 548
Sibo Jiang United States 13 26 0.2× 154 1.1× 45 0.5× 32 0.3× 33 0.4× 25 609

Countries citing papers authored by Mohammad Shafiei

Since Specialization
Citations

This map shows the geographic impact of Mohammad Shafiei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Shafiei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Shafiei more than expected).

Fields of papers citing papers by Mohammad Shafiei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Shafiei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Shafiei. The network helps show where Mohammad Shafiei may publish in the future.

Co-authorship network of co-authors of Mohammad Shafiei

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Shafiei. A scholar is included among the top collaborators of Mohammad Shafiei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Shafiei. Mohammad Shafiei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kargar, Pouya Ghamari, Mohammad Shafiei, & Ghodsieh Bagherzade. (2023). Transformation of 5-hydroxymethylfurfural to 5-hydroxymethyl-2-furan carboxylic acid mediated by silver nanoparticles biosynthesized from Spartium junceum flower extract. Materials Today Sustainability. 25. 100622–100622. 11 indexed citations
2.
Casselman, Jan, Mohammad Shafiei, Masoud Motasaddi Zarandy, et al.. (2022). Correlation of semi-quantitative findings of endolymphatic hydrops in MRI with the audiometric findings in patients with Meniere's disease. Journal of Otology. 17(3). 123–129. 3 indexed citations
3.
Küçükkılınç, Tuba Tüylü, Beyza Ayazgök, Hamid Nadri, et al.. (2022). Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease. Frontiers in Chemistry. 9. 810233–810233. 13 indexed citations
4.
Lotfali, Ensieh, et al.. (2021). Activities of Nanoparticles Against Fluconazole-Resistant Candida parapsilosis in Clinical Isolates. Assay and Drug Development Technologies. 19(8). 501–507. 5 indexed citations
5.
6.
Karizi, Shohreh Zare, et al.. (2021). Cell death analysis of recombinant mature epsilon toxin on the kidney cell line. Iranian Journal of Microbiology. 13(6). 832–838. 1 indexed citations
7.
Shafiei, Mohammad, Loghman Firoozpour, Tahmineh Akbarzadeh, et al.. (2021). Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Fluconazole-Based Compounds with Promising Antifungal Activities. ACS Omega. 6(38). 24981–25001. 17 indexed citations
8.
Erfani, Mostafa, et al.. (2018). Development of a 99m Tc-Labeled CXCR4 Antagonist Derivative as a New Tumor Radiotracer. Cancer Biotherapy and Radiopharmaceuticals. 33(1). 17–24. 12 indexed citations
9.
Erfani, Mostafa, et al.. (2018). Radiolabeling of zoledronic acid with 188Re as a new palliative agent radiotracer in treatment of bone tumors. Journal of Radioanalytical and Nuclear Chemistry. 316(2). 491–500. 4 indexed citations
10.
Erfani, Mostafa, et al.. (2017). Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis. Nuclear Medicine and Biology. 49. 1–7. 7 indexed citations
11.
Shamshirian, Danial, Mostafa Erfani, Davood Beiki, Babak Fallahi, & Mohammad Shafiei. (2015). Development of a 99mTc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors. Annals of Nuclear Medicine. 29(8). 709–720. 7 indexed citations
12.
Erfani, Mostafa, et al.. (2015). Radiocomplexation and evaluation of the 99mTc-Gemifloxacin in artificially Escherichia coli infected mice. Journal of Radioanalytical and Nuclear Chemistry. 308(3). 825–833. 4 indexed citations
13.
Erfani, Mostafa, et al.. (2014). A 99mTc‐tricine‐HYNIC‐labeled peptide targeting the neurotensin receptor for single‐photon imaging in malignant tumors. Journal of Labelled Compounds and Radiopharmaceuticals. 57(3). 125–131. 13 indexed citations
14.
Erfani, Mostafa & Mohammad Shafiei. (2014). Preparation of 99mTc-TRODAT-1 with high labeling yield in boiling water bath: A new formulation. Nuclear Medicine and Biology. 41(4). 317–321. 5 indexed citations
15.
Erfani, Mostafa, et al.. (2013). Preparation and Biological Evaluation of [ 99m Tc/EDDA/Tricine/HYNIC 0 , BzThi 3 ]-Octreotide for Somatostatin Receptor-Positive Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 28(3). 240–247. 7 indexed citations
16.
Erfani, Mostafa, et al.. (2012). Synthesis and biological evaluation of 99mTc(CO)3-OH-PP-CS2 for brain receptor imaging. 20(1). 25–31. 8 indexed citations
17.
Erfani, Mostafa, et al.. (2012). Synthesis, radiolabeling and bioevaluation of a novel arylpiperazine derivative containing triazole as a 5-HT1A receptor imaging agents. Nuclear Medicine and Biology. 40(2). 227–232. 6 indexed citations
18.
Shirmardi, Seyed Pezhman, et al.. (2011). Synthesis and evaluation of a new bombesin analog labeled with 99mTc as a GRP receptor imaging agent. Journal of Radioanalytical and Nuclear Chemistry. 288(2). 327–335. 17 indexed citations
19.
Najafi, Reza, et al.. (2009). Clinical evaluation of antimicrobial peptide [99mTc/Tricine/HYNIC0]ubiquicidin 29–41 as a human-specific infection imaging agent. Nuclear Medicine and Biology. 36(2). 199–205. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fereidoon Daryaee Breakdown of academic impact, for papers by Yong-Kang Zhang Breakdown of academic impact, for papers by Vidya P. Kumar Breakdown of academic impact, for papers by Catherine Piveteau Breakdown of academic impact, for papers by Andrew Chang Breakdown of academic impact, for papers by Weiguo Shi Breakdown of academic impact, for papers by Albert D. Friesen Breakdown of academic impact, for papers by Shoukath M. Ali Breakdown of academic impact, for papers by Sibo Jiang
Rankless by CCL
2026